サポート>ブログ>組換え抗体産生による抗体作製

組換え抗体産生による抗体作製

Biointron 2024-02-27
Recombinant-Antibodies.jpg
Image credit: DOI: 10.1007/s00114-002-0400-5

Recombinant antibody production is a revolutionary technology that has significantly impacted biomedical research and therapeutic applications. Unlike traditional antibody generation methods that rely on the immune response in animals, recombinant techniques involve the use of genetic engineering to produce antibodies with high specificity and reproducibility.  

Antibodies, or immunoglobulins, are pivotal to the immune response, recognizing and neutralizing pathogens such as bacteria and viruses. Traditionally, antibodies were produced by immunizing animals and extracting the serum. However, recombinant antibody production bypasses the need for animal immunization, using instead genetically modified cells to produce desired antibodies. 

Recombinant Antibody Production Process 

1. Gene Isolation and Cloning 

The process begins with isolating the gene that encodes the antibody of interest. This gene is then cloned into a vector, a DNA molecule used to transport genetic material into a host cell. 

2. Host Cell Selection and Modification 

Common host cells, including bacteria (E. coli), yeast, and mammalian cells, are genetically modified to incorporate the antibody gene. This modification enables the cells to produce the antibody. 

3. Cultivation and Expression 

The modified host cells are cultivated in bioreactors, where conditions are optimized for cell growth and antibody expression. This stage involves careful control of temperature, pH, and nutrient supply. 

4. Purification and Verification 

Following expression, the antibodies are purified from the culture medium. Techniques such as affinity chromatography ensure the isolation of high-purity antibodies. The specificity and activity of the antibodies are then verified through various assays. 

Advantages of Recombinant Antibody Production 

Recombinant antibodies offer several advantages over traditional methods, including higher specificity, the ability to produce antibodies against a wide range of antigens, and improved reproducibility. They can also be engineered to enhance their therapeutic efficacy. Recombinant antibodies have diverse applications, from therapeutic agents in the treatment of cancer, autoimmune diseases, and infections to diagnostic tools in medical research and clinical diagnostics.

Subscribe to our ブログ
Recommended Articles
2026 Networking Lunch Recap: “At the Table: Antibody Discovery”

Biointron’s Networking Lunch (At the Table: Antibody Discovery) was held at Cata……

Mar 17, 2026
International Women’s Day: Recognizing Women Driving Innovation in Biologics

Each year on International Women’s Day, the global community recognizes the achi……

Mar 08, 2026
AACR IO – Los Angeles: Highlights and Event Recap

​AACR Immuno-Oncology Conference (AACR IO) 2026 was held in Los Angeles from Feb……

Feb 23, 2026
Challenges in Bispecific Antibody Expression

Bispecific antibodies (bsAbs) are engineered molecules capable of simultaneously……

Feb 18, 2026

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。